Table 3 Injections details by GBCAa
Totala (N = 2118) | Clariscan (n = 1513) | Dotarem (n = 356) | Gadovist (n = 237) | |
|---|---|---|---|---|
Mean volume, mL, mean | 14.2 (3.4) | 15.0 (2.6) | 14.2 (3.2) | 8.5 (2.9) |
Mean dose, mmol/kg, mean (SD) | 0.10 (0.02) | 0.10 (0.02) | 0.10 (0.02) | 0.12 (0.04) |
Mean dose by type of procedure, mmol/kg, mean (SD) | ||||
MRI | 0.10 (0.02) | 0.10 (0.02) | 0.10 (0.02) | 0.11 (0.02) |
CNS | 0.10 (0.02) | 0.10 (0.01) | 0.10 (0.01) | 0.11 (0.02) |
Organ/whole body | 0.10 (0.02) | 0.10 (0.02) | 0.10 (0.02) | 0.11 (0.03) |
MRAb | 0.13 (0.04) | 0.11 (0.03) | 0.13 (0.04) | 0.18 (0.04) |
Dose category in mmol/kg, n (%) | ||||
≤ 0.1 | 1182 (55.8) | 887 (58.6) | 208 (58.4) | 80 (33.8) |
> 0.1–0.2 | 919 (43.4) | 623 (41.2) | 147 (41.3) | 144 (60.8) |
> 0.2–0.3 | 17 (0.8) | 3 (0.2) | 1 (0.3) | 13 (5.5) |
Injector use, n (%) | 1362 (64.3) | 998 (66.0) | 209 (58.7) | 146 (61.6) |
Subsequent saline injection, n (%) | 1461 (69.0) | 1032 (68.2) | 253 (71.1) | 167 (70.5) |
Saline injection volume, mL, mean (SD) | 17.2 (8.3) | 15.6 (8.6) | 21.9 (7.9) | 19.8 (1.7) |
Field strength | ||||
1.5 T | 1909 (90.1) | 1391 (91.9) | 311 (87.4) | 207 (87.3) |
3 T | 208 (9.8) | 122 (8.1) | 45 (12.6) | 29 (12.2) |
> 3 T | 1 (0.0) | 0 (0.0) | 0 (0.0) | 1 (0.4) |